ATE157774T1 - Verfahren zum nachweis der alzheimer-krankheit - Google Patents
Verfahren zum nachweis der alzheimer-krankheitInfo
- Publication number
- ATE157774T1 ATE157774T1 AT91301506T AT91301506T ATE157774T1 AT E157774 T1 ATE157774 T1 AT E157774T1 AT 91301506 T AT91301506 T AT 91301506T AT 91301506 T AT91301506 T AT 91301506T AT E157774 T1 ATE157774 T1 AT E157774T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- detecting alzheimer
- alzheimer
- detecting
- diagnozing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48514990A | 1990-02-26 | 1990-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE157774T1 true ATE157774T1 (de) | 1997-09-15 |
Family
ID=23927071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91301506T ATE157774T1 (de) | 1990-02-26 | 1991-02-26 | Verfahren zum nachweis der alzheimer-krankheit |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0444856B1 (de) |
JP (1) | JP3295098B2 (de) |
KR (1) | KR910021585A (de) |
AT (1) | ATE157774T1 (de) |
AU (2) | AU7121191A (de) |
CA (1) | CA2037105C (de) |
DE (1) | DE69127487T2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811310A (en) * | 1986-09-30 | 1998-09-22 | Albert Einstein College Of Medicine Of Yeshiva Univ. | The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease |
US5272055A (en) * | 1991-12-24 | 1993-12-21 | The University Of Kentucky Research Foundation | Detection of Alzheimer's disease and other diseases using a photoaffinity labeling method |
US5429947A (en) * | 1992-06-17 | 1995-07-04 | Merril; Carl R. | Diagnosing Alzheimer's disease and schizophrenia |
US6610493B1 (en) | 1993-06-17 | 2003-08-26 | Brigham And Women's Hospital | Screening compounds for the ability to alter the production of amyloid-β peptide |
US5766846A (en) * | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
US5837672A (en) * | 1992-07-10 | 1998-11-17 | Athena Neurosciences, Inc. | Methods and compositions for the detection of soluble β-amyloid peptide |
WO1995005604A2 (en) * | 1993-08-13 | 1995-02-23 | Molecular Geriatrics Corporation | Methods for the diagnosis of alzheimer's disease |
DE69426571T2 (de) | 1993-10-27 | 2001-08-09 | Elan Pharm Inc | TRANSGENE TIERE, DIE APP Allele mit der schwedischen Mutation beherbergen |
US7427392B1 (en) | 1994-11-14 | 2008-09-23 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
US5863902A (en) * | 1995-01-06 | 1999-01-26 | Sibia Neurosciences, Inc. | Methods of treating neurodegenerative disorders using protease inhibitors |
GB2346971B (en) * | 1999-02-19 | 2004-07-21 | Audrey Ann Coop | Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
PL2289909T3 (pl) | 2005-11-30 | 2015-04-30 | Abbvie Inc | Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał |
CN102898519B (zh) | 2005-11-30 | 2015-10-28 | Abbvie公司 | 抗淀粉样β蛋白的单克隆抗体及其用途 |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
EP2020602A1 (de) * | 2007-08-02 | 2009-02-04 | Araclon Biotech | Hochempfindliche Immuntests und Kits zur Bestimmung biologisch interessanter Peptide und Proteine |
EP2558494B1 (de) | 2010-04-15 | 2018-05-23 | AbbVie Inc. | Amyloid-beta-bindende proteine |
US9062101B2 (en) | 2010-08-14 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
MA44955A (fr) * | 2015-06-05 | 2019-03-20 | Ac Immune Sa | Anticorps anti-tau et leurs méthodes d'utilisation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666829A (en) * | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
CA1339014C (en) * | 1987-10-08 | 1997-03-25 | Ronald E. Majocha | Antibodies to a4 amyloid peptide |
GB8724412D0 (en) * | 1987-10-19 | 1987-11-25 | Medical Res Council | Protein |
EP0411974A1 (de) * | 1989-07-05 | 1991-02-06 | N.V. Innogenetics S.A. | Monoklonale Antikörper gegen neurofibrillisches Gewirrantigen |
-
1991
- 1991-02-19 AU AU71211/91A patent/AU7121191A/en not_active Abandoned
- 1991-02-25 KR KR1019910003026A patent/KR910021585A/ko not_active Application Discontinuation
- 1991-02-26 CA CA002037105A patent/CA2037105C/en not_active Expired - Fee Related
- 1991-02-26 DE DE69127487T patent/DE69127487T2/de not_active Expired - Fee Related
- 1991-02-26 JP JP05311791A patent/JP3295098B2/ja not_active Expired - Fee Related
- 1991-02-26 EP EP91301506A patent/EP0444856B1/de not_active Expired - Lifetime
- 1991-02-26 AT AT91301506T patent/ATE157774T1/de active
-
1994
- 1994-12-30 AU AU81854/94A patent/AU8185494A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH04216464A (ja) | 1992-08-06 |
DE69127487T2 (de) | 1998-01-08 |
EP0444856B1 (de) | 1997-09-03 |
CA2037105A1 (en) | 1991-08-27 |
KR910021585A (ko) | 1991-12-20 |
DE69127487D1 (de) | 1997-10-09 |
AU8185494A (en) | 1995-06-08 |
JP3295098B2 (ja) | 2002-06-24 |
EP0444856A3 (en) | 1991-12-27 |
CA2037105C (en) | 2008-12-09 |
EP0444856A2 (de) | 1991-09-04 |
AU7121191A (en) | 1991-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE157774T1 (de) | Verfahren zum nachweis der alzheimer-krankheit | |
DK451982A (da) | Fremgangsmaade og apparat til bestemmelse af antigeners tilstedevaerelse | |
DE3879000D1 (de) | Immunoassaymethode zum auffinden von antikoerpern zu antigenen. | |
ES537929A0 (es) | Un metodo de obtencion de factor de transferencia excretado (fte) especifico de un antigeno | |
SE8202012L (sv) | Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav | |
DE3783847D1 (de) | Verfahren und apparat fuer immunoassay. | |
RU93058563A (ru) | Полипептиды, иммунореагент, способ определения антител, способ индукции иммунного ответа, композиции, способ получения полипептида | |
DE69622425D1 (de) | Optischer apparat zur durchführung eines immunoassays | |
DE68927459D1 (de) | Nachweis einer neurologischen Krankheit oder einer Funktionsstörung | |
IT1219779B (it) | Procedimento di purificazione per affinita' in cui si impiegano anticorpi monoclonali | |
BE863810A (fr) | Procede de preparation d'un antigene et d'un anticorps | |
DE69003208D1 (de) | Verfahren und gerät zum herstellen von elektrofotografischen abdrucken von fotografischen negativen. | |
ATE71411T1 (de) | Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene. | |
DK99682A (da) | Immunoanalysemetoder under anvendelse af monoklonale antistoffer | |
DE69130135D1 (de) | Bildanalyseverfahren | |
NO302176B1 (no) | Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen | |
BE888906A (fr) | Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal | |
NO163920C (no) | Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever. | |
DE69007286D1 (de) | Verfahren zum fotografischen verfahren. | |
DE68914252D1 (de) | Verfahren zur Bestimmung eines Antigens. | |
DE69026875D1 (de) | Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür | |
DK717888A (da) | Monoklonale antistoffer | |
DE69021159D1 (de) | Verfahren zum immunochemischen Bestimmen von Haptenen. | |
DE3850993D1 (de) | Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2. | |
ATE104355T1 (de) | Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia. |